Context Therapeutics Inc. Quarterly Current Ratio in % from Q2 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Context Therapeutics Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q2 2024.
Context Therapeutics Inc. Current Ratio for the quarter ending June 30, 2024 was 1.17K %, a 19.7% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	1.17K	+193	+19.7%	Jun 30, 2024
Q1 2024	513	-645	-55.7%	Mar 31, 2024
Q4 2023	625	-818	-56.7%	Dec 31, 2023
Q3 2023	814	-765	-48.5%	Sep 30, 2023
Q2 2023	981	-202	-17.1%	Jun 30, 2023
Q1 2023	1.16K			Mar 31, 2023
Q4 2022	1.44K			Dec 31, 2022
Q3 2022	1.58K			Sep 30, 2022
Q2 2022	1.18K			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.